Head of Marketing​/Brand Lead, Sclerosis, US Neurology

Job Title:Head of Marketing / Brand Lead, Multiple Sclerosis, US Neurology

Location:Morristown, NJ, Cambridge, MA

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

Learn more at

The Head of Marketing, Multiple Sclerosis, US Neurology will be the founding US commercial leader for frexalimab
, a late-stage (Phase
3) neurology asset in Multiple Sclerosis
, with anticipated launch in Q4 2028
.

This individual will be the first US dedicated commercial hire for the asset and will play a pivotal role in shaping the future US brand from the ground up.

This role is accountable for building a deep understanding of the US MS market, defining the US value story for frexalimab, and designing the end-to-end go-to-market strategy in close partnership with the Global Brand Team and cross-functional US stakeholders. The Head of Marketing will operate as a strategic architect and integrator, laying the commercial foundation that will enable a successful launch and long-term brand growth.

This position requires comfort with ambiguity, strong strategic judgment, and the ability to lead without formal authority in a highly matrixed, pre-launch environment.

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

• Serve as the primary owner of US market understanding for frexalimab, including MS patient journey, diagnosis and referral dynamics, treatment paradigms, competitive landscape, and unmet need.
• Translate clinical data and emerging evidence into US-relevant value narratives for HCPs, patients, and payers.
• Lead US-focused market research, insight generation, and forecasting efforts to inform strategic decision-making.

• Design the US go-to-market strategy for frexalimab from first principles, including positioning, segmentation, targeting hypotheses, and launch sequencing.
• Define a clear US strategy for differentiation in a crowded market, including sequencing, switching and long‑term disease management considerations.
• Partner closely with Market Access to inform early pricing, access, and reimbursement scenarios appropriate for the US healthcare system.
• Define launch readiness requirements across marketing, medical, access, sales, patient services, and operations, ensuring alignment and integration, and driving execution to ensure Launch readiness.
• Lead development of the US Brand Plan and US Launch Plan in alignment with global strategy while advocating for US‑specific needs and trade‑offs.

• Act as the US commercial representative into the Global Brand Team, contributing meaningfully to global positioning, product profile development, and launch strategy.
• Provide strong US input into global decision‑making, challenging assumptions and ensuring US market realities are reflected.
• Collaborate closely with Global, Medical, Clinical, Regulatory, and Policy partners while maintaining a clear US commercial perspective.

• Lead US pre‑launch market shaping activities for frexalimab in partnership with Medical, Patient Advocacy, and Policy,…